The structure of a novel antibody against the spike protein inhibits Middle East respiratory syndrome coronavirus infections

Middle East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic virus, responsible for outbreaks of a severe respiratory illness in humans with a fatality rate of 30%. Currently, there are no vaccines or United States food and drug administration (FDA)-approved therapeutics for humans. The spi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Tae-Ho, Park, Woo-Jung, Lee, Hansaem, Woo, Hye-Min, Lee, So-young, Kim, Kyung-Chang, Kim, Sung Soon, Hong, Eunmi, Song, Jaeyoung, Lee, Joo-Yeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786824/
https://www.ncbi.nlm.nih.gov/pubmed/35075213
http://dx.doi.org/10.1038/s41598-022-05318-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786824/
https://www.ncbi.nlm.nih.gov/pubmed/35075213
http://dx.doi.org/10.1038/s41598-022-05318-4

Ejemplares similares